Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.
BACKGROUND
It is widely accepted that neuroinflammatory processes play an important role in the pathogenesis of Alzheimer's disease (AD) and high levels of cytokines and chemokines are detected around Aβ plaques.


METHODS
As neuroinflammation is involved in the development and progression of AD, we measured the pro-inflammatory cytokines interleukin 1β (IL-1β), IL-8 and tumor necrosis factor α (TNF-α) in serum and cerebrospinal fluid (CSF) samples from 45 AD patients and 53 age-matched control subjects using a highly sensitive multiplex electrochemiluminescence assay. To address the association with disease progression we correlated cognitive status with cytokine levels.


RESULTS
CSF as well as serum IL-8 levels were found to be significantly lower in AD patients than in controls (p = 0.02). A statistically significant inverse correlation was observed between the CSF level of IL-1β and the MMSE score (rs= -0.03, p = 0.02). We therefore stratified the AD patients by their MMSE scores into three equal groups and found that in the AD group with the most severe cognitive impairment CSF-IL-1β was significantly increased compared to age-matched controls (p < 0.05), whereas in the other investigated groups the increase was not statistically significant.


CONCLUSIONS
Our results confirm data suggesting that cytokine alterations are involved in AD pathogenesis and may be helpful as a biomarker for monitoring disease progression.
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Raphael
R
Hesse
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Anke
A
Wahler
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Pauline
P
Gummert
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Stefanie
S
Kirschmer
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Markus
M
Otto
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Hayrettin
H
Tumani
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Jan
J
Lewerenz
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Cathrin
C
Schnack
Department of Neurology, University of Ulm, Helmholtzstraße 8/1, 89081, Ulm, Germany. christine.arnim@uni-ulm.de.
Christine A F
CA
von Arnim
Alzheimer’s disease; Cytokines; Neuroinflammation
Longev Healthspan. 2012 Nov 01;1:8
24764513
J Neuroimmunol. 2008 Jan;193(1-2):183-7
18037502
Nat Rev Drug Discov. 2014 Jun;13(6):465-76
24854413
Lancet Neurol. 2015 Apr;14(4):388-405
25792098
Alzheimers Res Ther. 2010 Jan 22;2(1):1
20122289
Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):423-31
10817926
Mol Neurobiol. 2014 Oct;50(2):534-44
24567119
BMC Neurol. 2011 May 12;11:51
21569380
Vitam Horm. 2006;74:505-30
17027528
Neuro Oncol. 2005 Apr;7(2):122-33
15831231
J Neuroimmunol. 2000 Feb 1;103(1):97-102
10674995
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96
26122183
Cytokine. 1997 Sep;9(9):696-701
9325019
J Neurosci. 2008 Dec 24;28(52):14156-64
19109498
Am J Clin Pathol. 2008 Apr;129(4):526-9
18343778
Brain Res. 1993 Jan 8;600(1):49-55
8422590
Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):54-61
23242124
Alzheimers Res Ther. 2013 Dec 19;5(6):64
24351529
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5
2529544
J Alzheimers Dis. 2005 Mar;8(4):369-75
16556968
Mol Chem Neuropathol. 1996 Oct-Dec;29(2-3):237-52
8971699
Cytokine. 2000 Nov;12(11):1712-6
11052823
FASEB J. 2006 Apr;20(6):797-9
16481366
J Neuroimmunol. 1989 Oct;24(3):173-82
2808689
J Clin Neurol. 2008 Jun;4(2):84-8
19513308
Neurobiol Aging. 2001 Nov-Dec;22(6):957-66
11755004
J Immunol Methods. 2008 Jul 20;336(1):78-84
18495149
Brain Behav Immun. 2014 Oct;41:55-8
24858658
J Neuropathol Exp Neurol. 1995 Mar;54(2):276-81
7876895
Cell. 2012 Mar 16;148(6):1204-22
22424230
Glia. 1999 Dec;28(3):183-9
10559777
Acta Neuropathol. 2012 Jan;123(1):1-11
22101365
Neurobiol Aging. 2000 May-Jun;21(3):383-421
10858586
Neurobiol Aging. 1995 Sep-Oct;16(5):797-804
8532113
Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(3):247-54
2874657
Lancet. 2006 Jul 29;368(9533):387-403
16876668
Physiol Rev. 2001 Apr;81(2):741-66
11274343
Alzheimers Dement. 2012 Jan;8(1):1-13
22265587
Methods Find Exp Clin Pharmacol. 1991 Dec;13(10):703-8
1770834
Brain Res. 1999 Apr 24;826(1):112-6
10216202
Am J Pathol. 1999 Jun;154(6):1673-84
10362792
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1200-5
12933918
J Immunol Methods. 1992 Aug 30;153(1-2):115-24
1381403
J Neuroimmunol. 2005 Feb;159(1-2):66-74
15652404
Dement Geriatr Cogn Disord. 2006;21(5-6):291-5
16484807
Int J Alzheimers Dis. 2012;2012:165021
22655212
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10738-41
7479875
ScientificWorldJournal. 2012;2012:756357
22566778
Biol Psychiatry. 2010 Nov 15;68(10):930-41
20692646
J Neuropathol Exp Neurol. 1997 Apr;56(4):321-39
9100663
Methods Find Exp Clin Pharmacol. 1991 Sep;13(7):455-8
1784142
Arch Neurol. 2006 Apr;63(4):538-43
16606766
Neurobiol Aging. 1994 May-Jun;15(3):313-7
7936055
Neurology. 1984 Jul;34(7):939-44
6610841
Ann Neurol. 2003 Apr;53(4):547-8
12666129
Curr Alzheimer Res. 2014 May;11(4):325-31
24635842